Recent Findings in the Regulation of Programmed Death Ligand 1 Expression

With the recent approvals for the application of monoclonal antibodies that target the well-characterized immune checkpoints, immune therapy shows great potential against both solid and hematologic tumors. The use of these therapeutic monoclonal antibodies elicits inspiring clinical results with dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xiangfeng, Zhang, Lihong, Li, Jicheng, Li, Yulin, Wang, Yishu, Xu, Zhi-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587331/
https://www.ncbi.nlm.nih.gov/pubmed/31258527
http://dx.doi.org/10.3389/fimmu.2019.01337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587331/
https://www.ncbi.nlm.nih.gov/pubmed/31258527
http://dx.doi.org/10.3389/fimmu.2019.01337

Ejemplares similares